These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6756894)

  • 21. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
    Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
    J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
    Fasano A
    Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
    Su SF; Amidon GL; Lee HJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
    Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
    Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids.
    Gregoriadis G; Jain S; Papaioannou I; Laing P
    Int J Pharm; 2005 Aug; 300(1-2):125-30. PubMed ID: 16046256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.
    Kidron M; Dinh S; Menachem Y; Abbas R; Variano B; Goldberg M; Arbit E; Bar-On H
    Diabet Med; 2004 Apr; 21(4):354-7. PubMed ID: 15049938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a temporary "solubilizing" peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation.
    Hossain MA; Belgi A; Lin F; Zhang S; Shabanpoor F; Chan L; Belyea C; Truong HT; Blair AR; Andrikopoulos S; Tregear GW; Wade JD
    Bioconjug Chem; 2009 Jul; 20(7):1390-6. PubMed ID: 19552405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal peptide delivery using electroporation.
    Potts RO; Bommannan D; Wong O; Tamada JA; Riviere JE; Monteiro-Riviere NA
    Pharm Biotechnol; 1997; 10():213-38. PubMed ID: 9160374
    [No Abstract]   [Full Text] [Related]  

  • 31. Triggered release of an active peptide conjugate from a DNA device by an orally administrable small molecule.
    Taylor SK; Pei R; Moon BC; Damera S; Shen A; Stojanovic MN
    Angew Chem Int Ed Engl; 2009; 48(24):4394-7. PubMed ID: 19431176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption of peptide and peptidomimetic drugs.
    Amidon GL; Lee HJ
    Annu Rev Pharmacol Toxicol; 1994; 34():321-41. PubMed ID: 8042854
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liposomes as potential peptide active substance-carrier--studies with insulin as model (proceedings)].
    Axt J; Sarrach D; Zipper J; Mauersberger B
    Pharmazie; 1979; 34(5-6):350-1. PubMed ID: 515154
    [No Abstract]   [Full Text] [Related]  

  • 34. Stand and deliver: getting peptide drugs into the body.
    Wallace BM; Lasker JS
    Science; 1993 May; 260(5110):912-3. PubMed ID: 8493526
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral delivery of antibodies. Future pharmacokinetic trends.
    Reilly RM; Domingo R; Sandhu J
    Clin Pharmacokinet; 1997 Apr; 32(4):313-23. PubMed ID: 9113439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral administration of peptides.
    Saffran M
    Endocrinol Exp; 1982 Nov; 16(3-4):327-33. PubMed ID: 6756894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.
    Liang JF; Yang VC
    Biochem Biophys Res Commun; 2005 Sep; 335(3):734-8. PubMed ID: 16115469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzymatic barriers for GI peptide and protein delivery.
    Woodley JF
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):61-95. PubMed ID: 7600588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of chitosan for the oral administration of peptides.
    Prego C; Torres D; Alonso MJ
    Expert Opin Drug Deliv; 2005 Sep; 2(5):843-54. PubMed ID: 16296782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.